![](/img/cover-not-exists.png)
NIMG-26. EVALUATING THE DAYS GAINED RESPONSE METRIC IN CLINICAL TRIALS USING BEVACIZUMAB PLUS ADDITIONAL AGENTS FOR RECURRENT GLIOBLASTOMA
Singleton, Kyle, Johnston, Sandra, Rickertsen, Cassandra, Keith Anderson, S, De Leon, Gustavo, Whitmire, Scott, Clark-Swanson, Kamala, Bendok, Bernard, Mrugala, Maciej, Porter, Alyx, Galanis, EvanthiaVolume:
21
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz175.697
Date:
November, 2019
File:
PDF, 88 KB
2019